Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
- 17 years ago
QualityStocks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Radiation Dose Personalization into IzoView Breast CT System
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on advanced breast…
-
QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Awards Inaugural Sports.com Nations Trophy to Austria’s Jorden Dolischka
SEGG Media (NASDAQ: SEGG, LTRYW), a global sports, entertainment, and gaming conglomerate, celebrated a landmark…
-
QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Advances Development of ClearMetrX 4.0 With AI-Enhanced Healthcare Analytics
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company, announced its ClearMetrx subsidiary…